1066 — Shandong Weigao Medical Polymer Co Share Price
- HK$21.76bn
- HK$20.00bn
- CNY13.23bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 8.39 | ||
PEG Ratio (f) | 0.74 | ||
EPS Growth (f) | 12.78% | ||
Dividend Yield (f) | 3.63% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.9 | ||
Price to Tang. Book | 1.17 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.52 | ||
EV to EBITDA | 5.27 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 9.83% | ||
Return on Equity | 9.06% | ||
Operating Margin | 19.39% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 10,383.89 | 11,622.34 | 13,208.94 | 13,747.47 | 13,229.45 | 14,409.77 | 15,698.4 | 8.47% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +30.69 | +12.08 | +16.68 | +18.49 | -31.31 | +13.45 | +11.44 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
Directors
- Jing Long CHM (46)
- Rinan Cong CEO (40)
- Zhengpeng Tang NVC (50)
- Xuefeng Wu CFO
- Hong Feng Ju DGM (46)
- Miu Ling Wong SEC (52)
- Lin Chen NED (45)
- Xiaoming Lian NED (48)
- Ming Zhong Fu NID (70)
- Wai Hung Lo NID (61)
- Jin xia Wang NID (66)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 28th, 2000
- Public Since
- February 27th, 2004
- No. of Employees
- 12,519
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 4,570,632,324
- Address
- No.18 Xingshan Road, WEIHAI, 264210
- Web
- https://www.weigaoholding.com/
- Phone
- +86 6315621999
- Auditors
- Deloitte Touche Tohmatsu CPA
Upcoming Events for 1066
Dividend For 1066.HK - 0.0943 CNY
Half Year 2024 Shandong Weigao Group Medical Polymer Co Ltd Earnings Release
Similar to 1066
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:24 UTC, shares in Shandong Weigao Medical Polymer Co are trading at HK$4.76. This share price information is delayed by 15 minutes.
Shares in Shandong Weigao Medical Polymer Co last closed at HK$4.76 and the price had moved by -64.1% over the past 365 days. In terms of relative price strength the Shandong Weigao Medical Polymer Co share price has underperformed the FTSE Developed Asia Pacific Index by -62.53% over the past year.
The overall consensus recommendation for Shandong Weigao Medical Polymer Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Shandong Weigao Medical Polymer Co dividend yield is 1.65% based on the trailing twelve month period.
Last year, Shandong Weigao Medical Polymer Co paid a total dividend of CNY0.07, and it currently has a trailing dividend yield of 1.65%.Looking ahead, shares in Shandong Weigao Medical Polymer Co are due to go ex-dividend on 2024-06-03 and the next dividend pay date is 2024-07-12.
Shandong Weigao Medical Polymer Co are due to go ex-dividend on 2024-06-03 and the next dividend pay date is 2024-07-12. The historic dividend yield on Shandong Weigao Medical Polymer Co shares is currently 1.65%.
To buy shares in Shandong Weigao Medical Polymer Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$4.76, shares in Shandong Weigao Medical Polymer Co had a market capitalisation of HK$21.76bn.
Here are the trading details for Shandong Weigao Medical Polymer Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1066
Based on an overall assessment of its quality, value and momentum Shandong Weigao Medical Polymer Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Shandong Weigao Medical Polymer Co is HK$8.79. That is 84.56% above the last closing price of HK$4.76.
Analysts covering Shandong Weigao Medical Polymer Co currently have a consensus Earnings Per Share (EPS) forecast of CNY0.51 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shandong Weigao Medical Polymer Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -34.27%.
As of the last closing price of HK$4.76, shares in Shandong Weigao Medical Polymer Co were trading -32.15% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Shandong Weigao Medical Polymer Co PE ratio based on its reported earnings over the past 12 months is 8.39. The shares last closed at HK$4.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Shandong Weigao Medical Polymer Co's management team is headed by:
- Jing Long - CHM
- Rinan Cong - CEO
- Zhengpeng Tang - NVC
- Xuefeng Wu - CFO
- Hong Feng Ju - DGM
- Miu Ling Wong - SEC
- Lin Chen - NED
- Xiaoming Lian - NED
- Ming Zhong Fu - NID
- Wai Hung Lo - NID
- Jin xia Wang - NID